- Home
- SPRY vs CRTO Comparison
SPRY vs CRTO Comparison
Compare SPRY & CRTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRY
- CRTO
- Stock Information
- Founded
- SPRY 2015
- CRTO 2005
- Country
- SPRY United States
- CRTO France
- Employees
- SPRY N/A
- CRTO N/A
- Industry
- SPRY Biotechnology: Pharmaceutical Preparations
- CRTO Advertising
- Sector
- SPRY Health Care
- CRTO Consumer Discretionary
- Exchange
- SPRY Nasdaq
- CRTO Nasdaq
- Market Cap
- SPRY 1.6B
- CRTO 1.4B
- IPO Year
- SPRY N/A
- CRTO 2013
- Fundamental
- Price
- SPRY $17.61
- CRTO $23.15
- Analyst Decision
- SPRY Strong Buy
- CRTO Buy
- Analyst Count
- SPRY 4
- CRTO 11
- Target Price
- SPRY $28.75
- CRTO $44.70
- AVG Volume (30 Days)
- SPRY 1.6M
- CRTO 382.5K
- Earning Date
- SPRY 08-05-2025
- CRTO 07-31-2025
- Dividend Yield
- SPRY N/A
- CRTO N/A
- EPS Growth
- SPRY N/A
- CRTO 107.32
- EPS
- SPRY N/A
- CRTO 2.44
- Revenue
- SPRY $97,122,000.00
- CRTO $1,934,668,000.00
- Revenue This Year
- SPRY N/A
- CRTO N/A
- Revenue Next Year
- SPRY $170.64
- CRTO $1.96
- P/E Ratio
- SPRY N/A
- CRTO $9.70
- Revenue Growth
- SPRY 971120.00
- CRTO N/A
- 52 Week Low
- SPRY $8.91
- CRTO $23.17
- 52 Week High
- SPRY $18.90
- CRTO $49.93
- Technical
- Relative Strength Index (RSI)
- SPRY 60.67
- CRTO 37.05
- Support Level
- SPRY $16.40
- CRTO $23.60
- Resistance Level
- SPRY $18.22
- CRTO $25.37
- Average True Range (ATR)
- SPRY 0.97
- CRTO 0.66
- MACD
- SPRY 0.01
- CRTO 0.10
- Stochastic Oscillator
- SPRY 63.33
- CRTO 7.75
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About CRTO Criteo S.A.
Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.